 Celyad Oncology SA NASDAQ:CYAD Q2 2022 Earnings Conference Call August 5, 2022 8:00 AM ET Company Participants Sara Zelkovic - Director, Communications and Investor Relations Michel Lussier - Interim Chief Executive Officer Charlie Morris - Chief Medical Officer David Georges - Vice President of Finance and Administration Conference Call Participants Raju Prasad - William Blair Operator Greetings and welcome to the Celyad Oncology First Half 2022 Financial Results. At this time, all participants are in a listen-only mode. 